Literature DB >> 16612278

Liver retransplantation: a model for determining long-term survival.

Marcelo M Linhares1, Daniel Azoulay, Délcio Matos, Adauto Castelo-Filho, Tarcísio Triviño, Alberto Goldenberg, Denis Castaing, René Adam, Valerie Délvart, Phillipe Ichai, Fauze Saliba, Antoine Lemoine, Didier Samuel, Henry Bismuth.   

Abstract

BACKGROUND: Because of the worse results from retransplantation in relation to the initial liver transplantation, there is a need to refine the indication for retransplantation, such that fair distribution of this benefit is obtained.
METHODS: This was a study of 139 patients who underwent liver retransplantation. Thirty variables were studied: 18 relating to the recipient and 12 to the donor. All the independent variables were initially compared with the length of survival using univariate analyses. Variables presenting significance were compared with the dependent variable of length of survival, to determine which factors were related to longer survival among patients, when evaluated together.
RESULTS: A multivariate model for determining long-term survival among patients with retransplants was built up using the following variables: recipient's age, creatinine, urgency of retransplantation and early failure of the first graft. Through this multivariate model it was possible to determine a score that was categorized according to tertile distributions (below the 33rd percentile, score <24; 33rd to 66th percentile, 24 < or = score < or = 32; above the 66th percentile, score > 32). One-year, 3-year, and 5-year patient survival rates following retransplantation were respectively 85%, 82%, and 77% for scores <24; 69%, 66%, and 61% for scores between 24 and 32; and 21%, 19%, and 16% for scores >32 (P < 0.0001).
CONCLUSION: The variables of recipient's age, creatinine, urgency of retransplantation, and early failure of the initial transplantation were factors that were independently related to the long-term survival of patients with liver retransplants.

Entities:  

Mesh:

Year:  2006        PMID: 16612278     DOI: 10.1097/01.tp.0000203798.96491.2f

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

1.  Outcomes of liver retransplantation in patients with primary sclerosing cholangitis.

Authors:  Jacqueline B Henson; Yuval A Patel; Lindsay Y King; Jiayin Zheng; Shein-Chung Chow; Andrew J Muir
Journal:  Liver Transpl       Date:  2017-06       Impact factor: 5.799

2.  Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence.

Authors:  Alice Tung Wan Song; Rodolphe Sobesky; Carmen Vinaixa; Jérôme Dumortier; Sylvie Radenne; François Durand; Yvon Calmus; Géraldine Rousseau; Marianne Latournerie; Cyrille Feray; Valérie Delvart; Bruno Roche; Stéphanie Haim-Boukobza; Anne-Marie Roque-Afonso; Denis Castaing; Edson Abdala; Luiz Augusto Carneiro D'Albuquerque; Jean-Charles Duclos-Vallée; Marina Berenguer; Didier Samuel
Journal:  World J Gastroenterol       Date:  2016-05-14       Impact factor: 5.742

Review 3.  Recurrence of hepatitis C after liver transplantation.

Authors:  Carmen Vinaixa; Angel Rubín; Victoria Aguilera; Marina Berenguer
Journal:  Ann Gastroenterol       Date:  2013

4.  Liver retransplantation in adults: the largest multicenter Italian study.

Authors:  Umberto Maggi; Enzo Andorno; Giorgio Rossi; Luciano De Carlis; Umberto Cillo; Fabrizio Bresadola; Vincenzo Mazzaferro; Andrea Risaliti; Paolo Bertoli; Dario Consonni; Francesco Barretta; Tullia De Feo; Mario Scalamogna
Journal:  PLoS One       Date:  2012-10-05       Impact factor: 3.240

5.  Real World Utility of Dobutamine Stress Echocardiography in Predicting Perioperative Cardiovascular Morbidity and Mortality after Orthotopic Liver Transplantation.

Authors:  Akanksha Agrawal; Deepanshu Jain; Andre Dias; Vinicius Jorge; Vincent M Figueredo
Journal:  Korean Circ J       Date:  2018-04-25       Impact factor: 3.243

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.